2NH Stock Overview
Operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Naturhouse Health, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.64 |
| 52 Week High | €2.22 |
| 52 Week Low | €1.52 |
| Beta | 0.76 |
| 11 Month Change | 1.87% |
| 3 Month Change | -19.85% |
| 1 Year Change | 3.15% |
| 33 Year Change | -12.80% |
| 5 Year Change | -20.44% |
| Change since IPO | -68.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2NH | DE Specialty Retail | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.8% | 0.2% |
| 1Y | 3.2% | 17.2% | 8.5% |
Return vs Industry: 2NH underperformed the German Specialty Retail industry which returned 17.2% over the past year.
Return vs Market: 2NH underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| 2NH volatility | |
|---|---|
| 2NH Average Weekly Movement | 5.4% |
| Specialty Retail Industry Average Movement | 5.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 2NH has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2NH's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 197 | Felix Fernandez | www.naturhouse.com |
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products.
Naturhouse Health, S.A. Fundamentals Summary
| 2NH fundamental statistics | |
|---|---|
| Market cap | €101.61m |
| Earnings (TTM) | €9.74m |
| Revenue (TTM) | €49.90m |
10.4x
P/E Ratio2.0x
P/S RatioIs 2NH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2NH income statement (TTM) | |
|---|---|
| Revenue | €49.90m |
| Cost of Revenue | €14.18m |
| Gross Profit | €35.72m |
| Other Expenses | €25.97m |
| Earnings | €9.74m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 71.58% |
| Net Profit Margin | 19.53% |
| Debt/Equity Ratio | 4.6% |
How did 2NH perform over the long term?
See historical performance and comparison